Solna, Sweden, November 7, 2025 - Vivesto AB, an oncology-focused development company, today announced positive interim results obtained in Vivesto's open label, clinical pilot study with Paccal Vet i ...
Two canine osteosarcoma patients who underwent amputations are shown in 2023, when their care team and owners celebrated their final chemo treatments by ringing a bell and giving both dogs lots of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback